XPRS4PLEX-10
On-demand 4-in-1 PCR test delivering actionable results with less than 1 minute of hands-on time. FDA cleared: moderate complexity and CLIA waived
XPRS-COV2-10
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
XPRSTREPA-10
Delivers accurate and timely results that optimizes fast treatment decisions
XPRSFLU-10
Qualitative detection and differentiation of influenza A and influenza B
XPRSFLU/RSV-10
Co-labeled Moderate Complexity and CLIA-Waived. Fast, accurate and reliable detection of Flu A, Flu B and/or RSV in one test
GXGI-10
Detection and identification of DNA and RNA from multiple bacteria, parasites and/or virus in ~ 74 minutes
GXSACOMP-10
Detection of S. aureus and MRSA in about 65 minutes
GXMRSA/SA-SSTI-10
Detect MRSA & SA Skin and Soft Tissue Infections in 62 minutes
GXNOV-10
Fast detection of Norovirus GI & GII with results available in 90 minutes
GXCDIFF/EPI-10
Detection and differentiation of C. difficile & the epidemic 027 strain in <45 minutes
GXMRSA/SA-BC-10
MRSA and S. aureus detection from gram-positive blood culture samples in 62 minutes
GXMRSA-NXG-10
Active MRSA Surveillance testing in around 70 minutes
GXVANA-10
Rapid VRE screening for active outbreak prevention and control in around 48 minutes
GXCARBAR-10
Detection and differentiation of KPC, NDM, VIM, IMP, and OXA-48 in 50 minutes
XPRSMVP-10
Multiplex vaginal panel that enables results within 60 minutes from a single specimen for Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis
GXCT/NG-10
90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
GXGBSLBXC-10
Detection of Group B Streptococcus with dual target with results within one hour
GXTV-10
Fast molecular detection of Trichomonas vaginalis for both women and men.
XPRSGBS-10
Qualitative real-time PCR test providing accurate intrapartum detection of Group B Streptococcus in labor/delivery
GXHCV-SPAK
Point-of-care hepatitis C RNA test that enables same-day linkage to care
GXMPX-10
On-demand Mpox testing provides qualitative point-of-care results in approximately 36 minutes, with EAT results as soon as 25 minutes. For use under an Emergency Use Authorization in the United States
GXMTB/RIF-US-10
Accurate Detection of MTB and Rifampin Resistance Mutations
XPRSTREPA-10
Delivers accurate and timely results that optimizes fast treatment decisions
GXFIIFV-10
30-Minute Test for Genetic Risk of Thrombosis
GXBCRABL-US-10
Delivering MORE confidence with fast, accurate Chronic Myeloid Leukemia molecular monitoring results
Available in 4, 16, 48, or 80-module configurations, each system has Cepheid’s proven GeneXpert® module at its analytic core and uses our patented cartridge technology for every Xpert® test. The platform is standardized yet scalable across the healthcare continuum — from hospital labs to emergency departments and decentralised settings.
Article
4m Read
May 19, 2025
RESPIRATORY HEALTH
Article
5m Read
January 07, 2026
TECH AND DISEASE TRENDS
